LXR Modulator Compounds for Dermal Barrier Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for dermal diseases and conditions such as skin aging, psoriasis, and skin cancer lack effective modulation of liver X receptor (LXR) activation, which is crucial for maintaining the dermal barrier and reducing inflammation.
Innovation Solution
Development of compounds of Formula E and V, which are LXR modulators, for topical application to stimulate epidermal differentiation, lipid production, and reduce inflammation, thereby improving the dermal barrier function and treating various skin conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If LXR activation is used to treat dermal diseases, then inflammation is reduced and dermal barrier function is improved, but current treatments lack effective LXR modulation
Solution Approach 1:
The patent modifies molecular parameters by designing compounds with specific structural features (Formula E and V) that optimize LXR binding affinity and modulatory activity, transforming existing treatments into effective LXR modulators
Solution Approach 2:
The patent introduces LXR as an intermediary target between existing treatments and dermal disease outcomes, where LXR modulators mediate the therapeutic effect by regulating inflammation and barrier function through LXR activation
2Productivity
If LXR modulators are developed for topical application, then epidermal differentiation and lipid production are stimulated, but compound structure complexity increases
Solution Approach 1:
The patent applies local quality by introducing specific functional groups and substituents at particular positions in the molecular structure (as defined in Formula E and V) to achieve LXR modulatory activity while maintaining overall structural manageability
Solution Approach 2:
The patent segments the complex molecular structure into defined components (Formula E and V with specific R groups and structural elements) that can be independently optimized and combined to achieve desired LXR modulatory effects
Data Source
Figure 1
Figure 2
AI summary
Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of dermal diseases, disorders or conditions. Also described herein are pharmaceutical compositions containg such compounds.